日本のオーソバイオロジクス市場：2033年までの見通し - オーソバイオロジクス、軟骨修復、その他

当レポートでは、日本のオーソバイオロジクス市場について調査し、市場の概要とともに、2033年までの市場予測、主要参入企業のプロファイル、およびパイプライン製品などを提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 日本におけるオーソバイオロジクス市場

• オーソバイオロジクス市場、日本、収益（100万米ドル）、2018年～2033年
• オーソバイオロジクス市場、日本、数量（個）、2018年～2033年
• オーソバイオロジクス市場、日本、平均価格（米ドル）、2018年～2033年
• オーソバイオロジクス市場、日本、収益別流通シェア（100万米ドル）、2023年
• オーソバイオロジクス市場、日本、収益別企業シェア（100万米ドル）、2023年

第4章 日本の主要企業の概要、オーソバイオロジクス市場

• Medtronic Plc
• Sanofi
• Seikagaku Corp
• Stryker Corp
• Zimmer Biomet Holdings Inc
• Smith & Nephew Plc
• Ferring Pharmaceuticals AS

第5章 オーソバイオロジクス市場のパイプライン製品

第6章 最近の動向

第7章 付録

List of Tables

• Table 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Table 2: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Table 3: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Table 4: Cartilage Repair Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Table 5: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Table 6: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Table 7: Orthobiologics Market, Japan, Volume (Units), 2018-2033
• Table 8: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2018-2033
• Table 9: Bone Growth Stimulators Market, Japan, Volume (Units), 2018-2033
• Table 10: Cartilage Repair Market, Japan, Volume (Units), 2018-2033
• Table 11: Soft Tissue Biologics Market, Japan, Volume (Units), 2018-2033
• Table 12: Viscosupplementation Market, Japan, Volume (Units), 2018-2033
• Table 13: Orthobiologics Market, Japan, Average Price ($), 2018-2033
• Table 14: Orthobiologics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023
• Table 15: Orthobiologics Market, Japan, Company Share by Revenue ($m), USD Constant, 2023
• Table 16: Orthobiologics Market Pipeline Products
• Table 17: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

• Figure 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Figure 2: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Figure 3: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Figure 4: Cartilage Repair Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Figure 5: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Figure 6: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Figure 7: Orthobiologics Market, Japan, Volume (Units), 2018-2033
• Figure 8: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2018-2033
• Figure 9: Bone Growth Stimulators Market, Japan, Volume (Units), 2018-2033
• Figure 10: Cartilage Repair Market, Japan, Volume (Units), 2018-2033
• Figure 11: Soft Tissue Biologics Market, Japan, Volume (Units), 2018-2033
• Figure 12: Viscosupplementation Market, Japan, Volume (Units), 2018-2033
• Figure 13: Orthobiologics Market, Japan, Company Share (%) 2023

GlobalData's "Japan Orthobiologics Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Japan Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Orthobiologics, Cartilage Repair and Others

The Japan Orthobiologics Market report provides key information and data on -

• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Orthobiologics Market.
• Global corporate-level profiles of key companies operating within the Japan Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Japan Orthobiologics is segmented as follows -

• Bone Grafts and Substitutes
• Bone Growth Stimulators
• Cartilage Repair
• Soft Tissue Biologics
• Viscosupplementation

Reasons to Buy

Japan Orthobiologics Market report helps you to develop -

• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 What Is This Report About?
• 2.2 Orthobiologics Market Segmentation
• 2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, Japan

• 3.1 Orthobiologics Market, Japan, Revenue ($m), 2018-2033
  • 3.1.1 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2018-2033
  • 3.1.2 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2018-2033
  • 3.1.3 Cartilage Repair Market, Japan, Revenue ($m), by Segment, 2018-2033
  • 3.1.4 Soft Tissue Biologics Market, Japan, Revenue ($m), by Segment, 2018-2033
  • 3.1.5 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2018-2033
• 3.2 Orthobiologics Market, Japan, Volume (Units), 2018-2033
  • 3.2.1 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2018-2033
  • 3.2.2 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2018-2033
  • 3.2.3 Cartilage Repair Market, Japan, Volume (Units), by Segment, 2018-2033
  • 3.2.4 Soft Tissue Biologics Market, Japan, Volume (Units), by Segment, 2018-2033
  • 3.2.5 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2018-2033
• 3.3 Orthobiologics Market, Japan, Average Price ($) , 2018-2033
• 3.4 Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2023
• 3.5 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in Japan, Orthobiologics Market

• 4.1 Medtronic Plc
  • 4.1.1 Company Overview
• 4.2 Sanofi
  • 4.2.1 Company Overview
• 4.3 Seikagaku Corp
  • 4.3.1 Company Overview
• 4.4 Stryker Corp
  • 4.4.1 Company Overview
• 4.5 Zimmer Biomet Holdings Inc
  • 4.5.1 Company Overview
• 4.6 Smith & Nephew Plc
  • 4.6.1 Company Overview
• 4.7 Ferring Pharmaceuticals AS
  • 4.7.1 Company Overview

5 Orthobiologics Market Pipeline Products

6 Recent Developments

• 6.1 Financial Announcements
  • 6.1.1 Dec 20, 2023: Significant Health & Quality of Life Improvements Achieved in Children with Achondroplasia Treated for One Year with TransCon CNP at 100 µg/kg/week

7 Appendix

• 7.1 Research Methodology
  • 7.1.1 Coverage
  • 7.1.2 Secondary Research
  • 7.1.3 Primary Research
  • 7.1.4 Market Modeling and Forecasting
  • 7.1.5 Company Share Analysis
  • 7.1.6 Distribution Share Analysis
  • 7.1.7 Benchmarking
• 7.2 GlobalData Consulting
• 7.3 Contact Us
• 7.4 Disclaimer